Use of clarithromycin in the outpatient setting appears to be associated with long-term increases in mortality, a retrospective study has found. Additionally, erythromycin yields a similar, albeit smaller, increase in the said risk.
An association exists between proprotein convertase subtilisin/kexin type 9 (PCSK9)-low-density lipoprotein receptor (LDLR) axis and outcomes in patients with heart failure (HF), according to a recent study.
Left ventricular ejection fraction (LVEF), ischaemic cardiomyopathy and comorbidities are associated with all-cause mortality in patients receiving a primary prophylactic implantable cardioverter defibrillator (ICD), according to a recent study.
Cardiac resynchronization therapy (CRT) using quadripolar leads with repetitive optimized left ventricular pacing configurations (LVPCs) provides larger left ventricular ejection fraction (LVEF) increases than conventional bipolar leads, a new study shows.
Chronic pain, cardiovascular diseases (CVD) and depression may have shared genetic or familial links, as suggested by an increased co-occurrence in both general population-based and twins cohort, a recent study shows.
The fixed-dose combination of amlodipine/losartan potassium/chlorthalidone (A/L/C) demonstrates superior blood pressure (BP)–lowering efficacy while having a good safety profile in the treatment of patients with stage 2 hypertension inadequately controlled by A/L, according to the results of a phase III study.
Higher circulating levels of docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) appear to be protective against incident atherothrombotic and cardioembolic strokes, respectively, according to a recent study.
diseases (CVD) have been the main cause of death in the Malaysian population since
2007. This trend has continued, with the number of people dying from
CVD-related causes increasing year on year.
Intensive blood pressure (BP) lowering appears to reduce mortality risk during treatment in individuals with hypertension and moderate-to-advanced chronic kidney disease (CKD), findings from a recent systematic review and meta-analysis show.
The risk of coronary heart disease (CHD), cerebrovascular disease and heart failure is greater among metabolically healthy obese than normal weight metabolically healthy individuals, suggests a recent study. Additionally, even those who are normal weight can have metabolic abnormalities and similar risks for cardiovascular disease (CVD) events.